Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep77 | Adrenal and Cardiovascular Endocrinology | ECE2020

Primary aldosteronism : Study of 09 cases

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Introduction: Primary aldosteronism (PHA), also known as primary hyperaldosteronism or Conn’s syndrome, refers to the excess production of the hormone aldosterone from the adrenal glands.Study objectives: To show clinical, biochemical, and morphological data of 09 patients with primary hyperaldosteronism as well as the therapeutic choice for each patientMehtods: it is aretrospective and descriptive study of 09 cases with prim...

ea0070ep163 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Bariatric surgery : About 10 cases

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Meftah Azelarab , Barni Rachid El , Youssef Qamouss , Baizri Hicham

Introduction: Bariatric surgery is the treatment which has shown the most important effectiveness in terms of weight reduction, improvement of co morbidities, quality of life and mortality on the long term, in the case of massive obesity and obesity associated with co–morbidities. The purposes of our study: clarify the place of bariatric surgery in the treatment of obesity, define the criteria of selections of patients.Material and Methods: It&#821...

ea0070ep191 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The serological prevalence of celiac disease (cd) in patients with type 1 diabetes (dt1)

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Introduction: Celiac disease is an autoimmune disease triggered by gluten frequently associated with other autoimmune diseases, among which is type 1 diabetes first.Objectives: The objectives of our study are:– To determine the serological prevalence of celiac disease (CD) in patients with type 1 diabetes (DT1)– Compare the clinical and biological characteristics of seropositive and seronegative p...

ea0070ep521 | Thyroid | ECE2020

Radioiodine therapy and Graves’ disease

Lahousssaine Abainou , El Jadi Hamza , Idrissi Ayoub , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Used for the first time in 1941 in the United States by Hertz and Roberts for the treatment of hyperthyroidism in Grave’s Disease, radioactive active therapy (RAI) has been able to gain its place within the already existing therapeutic arsenal by being efficient, easy to use and minimally invasive. Our work is a retrospective study of 46 patients collected at the Department of Endocrinology, over a period of 7 years and half from January 1, 2011 to June 30, 2018. The pur...